Ponni Anand is the Director of Business Development at Cellero. She has a strong background in pre-clinical and clinical research in immunotherapy and gene and stem cell therapy. Learn more about Ponni.

Cellero Immune Cells Provide Answers in Leukemia Study

Independent researchers cite using Cellero primary human immune cells in their recently published study on the mechanisms underlying development of acute myeloid leukemia. [1] This publication represents a broad collaborative effort across a number of renowned research institutes, including Memorial Sloan Kettering and Fred Hutchinson Cancer Research Centers, and Cornell University. The research team want…

Disease State PBMCs Help Unlock Pathogenesis of Autoimmunity

Autoimmune diseases are chronic conditions that often occur in individuals with genetic predispositions toward that disease. The pathological mechanisms that lead to onset of disease vary and are not fully understood by modern science. Autoimmune diseases, such as celiac disease, lupus, and multiple sclerosis, are all characterized by the inappropriate inflammation and damage that result…